How much does Bloomberg Terminal cost in 2026?

Bloomberg Terminal costs $24,240 per user per year (≈ $2,020/month) for the standard subscription. The price has been broadly stable for over a decade. Volume discounts exist for institutional buyers above a certain seat count, but the per-seat list price is the figure most retail investors and small advisors will face.

Is there a truly free Bloomberg Terminal alternative?

No alternative replicates Bloomberg's data breadth (real-time fixed income, FX, commodities, derivatives, news, chat) at zero cost. There are credible free tiers for specific slices: TradingView for charting, Koyfin for equity fundamentals + macro dashboards, MEDGE Capital for portfolio analytics + SEC/CFTC/ECB regulatory data. The right alternative depends on which 5–10% of Bloomberg you actually use.

Who actually needs Bloomberg Terminal vs an alternative?

Bloomberg is right for: sell-side traders needing real-time quotes across thousands of instruments, fixed-income desks with Bloomberg-native execution, M&A bankers using the IB platform, anyone needing the chat (Instant Bloomberg) for liquidity. Alternative tools are right for: retail investors, independent advisors, equity-focused analysts, portfolio managers with periodic (not tick-level) workflow.

Where does MEDGE Capital fit in the Bloomberg-alternative landscape?

MEDGE Capital fills the portfolio + risk methodology + regulatory data slot. Koyfin covers equity fundamentals and advisor workflow at $39-79/month; Portfolio Visualizer covers factor regression at $30-55/month; MEDGE Capital covers CVaR/Monte Carlo/12 optimization objectives + SEC 13F + CFTC COT + FCA SPR + ECB balance sheets at €14.99/month. Many serious users keep 2-3 of these tools open instead of paying for one Bloomberg.

What does MEDGE Capital NOT have that Bloomberg does?

No real-time tick data, no integrated trade execution, no fixed-income desk tools, no Bloomberg Messenger / IB Chat, no proprietary news terminal, no built-in derivatives pricing engine, no FX swap pricing. MEDGE is a portfolio + risk + regulatory analytics platform, not an execution terminal. If your workflow needs tick-by-tick or you trade fixed income institutionally, Bloomberg is the right tool.

Comparison · Bloomberg Terminal Alternative

Bloomberg Terminal alternative (2026): the honest landscape.

Bloomberg Terminal costs $24,240/user/year (~$2,020/month) in 2026 — broadly stable for over a decade. No single alternative replicates its full breadth, but the right slice of Bloomberg is now available at retail pricing across 3–4 specialised platforms. MEDGE Capital covers the portfolio + risk methodology + regulatory-data slot at €14.99/month — 1/130th the cost for the 5–10% of Bloomberg most retail-pro users actually need.

The pricing reality

$24,240 /yr

Bloomberg Terminal per user

~$960 /yr

Koyfin Premium ($79/mo)

€180 /yr

MEDGE Capital Pro (€14.99/mo)

Try MEDGE Capital freeFree tier with no time limit · Pro from €14.99/month

What Bloomberg gives that no alternative replicates

Honest concession first. There are five capabilities for which Bloomberg is structurally the only answer — no alternative gets close. If your workflow depends on any of these, no €15-79/mo tool will replace it.

Real-time tick data across asset classes

Equities, fixed income, FX, commodities, derivatives — milliseconds latency, normalised feed.

Fixed-income desk depth

Bond pricing, yield curves, credit spreads, primary issuance — every workflow built natively into the platform.

Instant Bloomberg (IB Chat)

The de-facto liquidity messaging network for institutional desks. Sell-side bid/ask, RFQ, news flow.

Built-in execution

EMSX, FXGO — execution venues integrated, no third-party EMS required.

Breadth of news + analytics

Bloomberg News, premium analysts, deep historical archives. Compound network effects.

What you do get at retail pricing — and from whom

The retail-pro alternatives have specialised: each covers one slice of Bloomberg deeply, not the whole. Pick by workflow.

Portfolio + Risk + Regulatory data

MEDGE Capital

Free · Pro €14.99/mo · Enterprise €59.99/mo

·CVaR 95/99 + Monte Carlo + 12 optimization objectives
·SEC 13F + Form 4 + CFTC COT + FCA SPR
·Fed/ECB/BoJ/BoE balance sheets, ECB SHS
·Crisis Library backtests (2008/2020/2022/2018Q4)
·Multi-currency, UCITS coverage, AI-narrated PDF

Open MEDGE platform

Equity fundamentals + advisor workflow

Koyfin

Free tier · Plus $39/mo · Premium $79/mo

·Capital IQ-backed fundamentals (income, balance, cash flow)
·Dividend analytics + screening
·Proposal generation + RIA tools
·Macro dashboards (global indicators)
·Watchlists + global stocks

Visit Koyfin

Factor regression + classic backtesting

Portfolio Visualizer

Free (15 assets) · $360/yr Basic · $660/yr Pro

·Fama-French 3-factor + Carhart 4-factor regression
·Mean-variance optimization
·Tactical asset allocation backtesting
·13 years of curated US ticker data
·Annual billing only

Visit Portfolio Visualizer

Charting + screening + community

TradingView

Free · Plans $14.95-59.95/mo

·20M+ active users globally
·Advanced charting, multi-timeframe
·Stock + ETF + crypto + FX screeners
·Social trading network
·Paper trading + broker integrations

Visit TradingView

Which alternative is right for you?

You manage a multi-asset portfolio and care about risk methodology + regulatory positioning → MEDGE Capital. €14.99/mo gives you CVaR + 12 optimization objectives + SEC 13F + CFTC COT — none of the others ship this combination.
You spend most of your day on bottom-up equity research → Koyfin. Capital IQ-backed fundamentals at retail pricing is the genuine Bloomberg-light value proposition.
You run factor regression / mean-variance optimization on US equities → Portfolio Visualizer. The 13-year US ticker dataset + polished factor module is unmatched.
You need advanced charting, multi-asset screeners, or community → TradingView. 20M users, free tier is genuinely usable.
You actually need real-time tick + execution + IB Chat → Bloomberg Terminal. No alternative is close. Budget the $24,240/year or accept it isn't for retail use.
Honest pattern most users converge to: MEDGE Capital + Koyfin (or Portfolio Visualizer) running side-by-side. Combined cost ~€55-100/month for the 5-10% of Bloomberg that matters to retail-pro workflow.

Frequently asked

How much does Bloomberg Terminal cost in 2026?: Bloomberg Terminal costs $24,240 per user per year (≈ $2,020/month) for the standard subscription. The price has been broadly stable for over a decade. Volume discounts exist for institutional buyers above a certain seat count, but the per-seat list price is the figure most retail investors and small advisors will face.
Is there a truly free Bloomberg Terminal alternative?: No alternative replicates Bloomberg's data breadth (real-time fixed income, FX, commodities, derivatives, news, chat) at zero cost. There are credible free tiers for specific slices: TradingView for charting, Koyfin for equity fundamentals + macro dashboards, MEDGE Capital for portfolio analytics + SEC/CFTC/ECB regulatory data. The right alternative depends on which 5–10% of Bloomberg you actually use.
Who actually needs Bloomberg Terminal vs an alternative?: Bloomberg is right for: sell-side traders needing real-time quotes across thousands of instruments, fixed-income desks with Bloomberg-native execution, M&A bankers using the IB platform, anyone needing the chat (Instant Bloomberg) for liquidity. Alternative tools are right for: retail investors, independent advisors, equity-focused analysts, portfolio managers with periodic (not tick-level) workflow.
Where does MEDGE Capital fit in the Bloomberg-alternative landscape?: MEDGE Capital fills the portfolio + risk methodology + regulatory data slot. Koyfin covers equity fundamentals and advisor workflow at $39-79/month; Portfolio Visualizer covers factor regression at $30-55/month; MEDGE Capital covers CVaR/Monte Carlo/12 optimization objectives + SEC 13F + CFTC COT + FCA SPR + ECB balance sheets at €14.99/month. Many serious users keep 2-3 of these tools open instead of paying for one Bloomberg.
What does MEDGE Capital NOT have that Bloomberg does?: No real-time tick data, no integrated trade execution, no fixed-income desk tools, no Bloomberg Messenger / IB Chat, no proprietary news terminal, no built-in derivatives pricing engine, no FX swap pricing. MEDGE is a portfolio + risk + regulatory analytics platform, not an execution terminal. If your workflow needs tick-by-tick or you trade fixed income institutionally, Bloomberg is the right tool.

The portfolio + regulatory slice — at €14.99/month.

1/130th the Bloomberg list price for the 5–10% retail-pro users actually need. Free tier with no time limit, Pro 7-day trial, cancel anytime.

Start free — no card required

Bloomberg, Bloomberg Terminal, Capital IQ, Koyfin, Portfolio Visualizer and TradingView are trademarks of their respective owners. MEDGE Capital is independent, not affiliated with any of them. Pricing reflects publicly listed information as of June 2026; verify with each vendor before deciding.